Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel.
Mevorach D, Anis E, Cedar N, Hasin T, Bromberg M, Goldberg L, Levi N, Perzon O, Magadle N, Barhoum B, Parnassa E, Dichtiar R, Hershkovitz Y, Green MS, Ash N, Keinan-Boker L, Alroy-Preis S. Mevorach D, et al. Among authors: anis e. Circulation. 2022 Sep 6;146(10):802-804. doi: 10.1161/CIRCULATIONAHA.122.060961. Epub 2022 Sep 6. Circulation. 2022. PMID: 36067275 Free PMC article. No abstract available.
Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal influenza among children, Israel.
Engelhard D, Bromberg M, Averbuch D, Tenenbaum A, Goldmann D, Kunin M, Shmueli E, Yatsiv I, Weintraub M, Mandelboim M, Strauss-Liviatan N, Anis E, Mendelson E, Shohat T, Wolf DG, Shapiro M, Grotto I. Engelhard D, et al. Among authors: anis e. Emerg Infect Dis. 2011 Sep;17(9):1740-3. doi: 10.3201/eid1709.102022. Emerg Infect Dis. 2011. PMID: 21888809 Free PMC article.
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
Reicher S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, Mossinson D, Shenhar Y, Friger M, Lustig Y, Alroy-Preis S, Anis E, Sadetzki S, Kaliner E. Reicher S, et al. Among authors: anis e. Eur J Epidemiol. 2021 Jul;36(7):727-734. doi: 10.1007/s10654-021-00749-1. Epub 2021 Apr 21. Eur J Epidemiol. 2021. PMID: 33884542 Free PMC article.
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, Brooks N, Smaja M, Mircus G, Pan K, Southern J, Swerdlow DL, Jodar L, Levy Y, Alroy-Preis S. Haas EJ, et al. Among authors: anis e. Lancet. 2021 May 15;397(10287):1819-1829. doi: 10.1016/S0140-6736(21)00947-8. Epub 2021 May 5. Lancet. 2021. PMID: 33964222 Free PMC article.
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
Haas EJ, McLaughlin JM, Khan F, Angulo FJ, Anis E, Lipsitch M, Singer SR, Mircus G, Brooks N, Smaja M, Pan K, Southern J, Swerdlow DL, Jodar L, Levy Y, Alroy-Preis S. Haas EJ, et al. Among authors: anis e. Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22. Lancet Infect Dis. 2022. PMID: 34562375 Free PMC article.
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
Mevorach D, Anis E, Cedar N, Bromberg M, Haas EJ, Nadir E, Olsha-Castell S, Arad D, Hasin T, Levi N, Asleh R, Amir O, Meir K, Cohen D, Dichtiar R, Novick D, Hershkovitz Y, Dagan R, Leitersdorf I, Ben-Ami R, Miskin I, Saliba W, Muhsen K, Levi Y, Green MS, Keinan-Boker L, Alroy-Preis S. Mevorach D, et al. Among authors: anis e. N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi: 10.1056/NEJMoa2109730. Epub 2021 Oct 6. N Engl J Med. 2021. PMID: 34614328 Free PMC article.
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study.
Singer SR, Angulo FJ, Swerdlow DL, McLaughlin JM, Hazan I, Ginish N, Anis E, Mendelson E, Mor O, Zuckerman NS, Erster O, Southern J, Pan K, Mircus G, Lipsitch M, Haas EJ, Jodar L, Levy Y, Alroy-Preis S. Singer SR, et al. Among authors: anis e. EClinicalMedicine. 2021 Dec;42:101190. doi: 10.1016/j.eclinm.2021.101190. Epub 2021 Nov 29. EClinicalMedicine. 2021. PMID: 34870134 Free PMC article.
154 results